Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← David Abrams, latest 13F

Akebia Therapeutics

In David Abrams's portfolio · Abrams Capital Management

Ticker AKBA

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Abrams Capital Management 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q4 2020 Sell 0  
Q3 2020 No change 5,656,462 0.4% $2.51 $14.2M
Q2 2020 No change 5,656,462 2.5% $13.58 $76.8M
Q1 2020 No change 5,656,462 1.7% $7.58 $42.9M
Q4 2019 No change 5,656,462 1.1% $6.32 $35.7M
Q3 2019 No change 5,656,462 0.6% $3.92 $22.2M
Q2 2019 No change 5,656,462 0.7% $4.84 $27.4M
Q1 2019 No change 5,656,462 1.3% $8.19 $46.3M
Q4 2018 Add 405% 5,656,462 1.3% $5.53 $31.3M
Q3 2018 Buy 1,119,286 0.3% $8.83 $9.9M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.